Semi-annual Performance Forecast for 2026
Filed with SSE · · 2 pages · Chinese
Lionco Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Lionco Pharmaceutical
- Announcement on Conversion Result of Convertible Bonds and Share Changes
- Announcement on Follow-up Rating Results of "Lionco Convertible Bonds" in 2026
- Announcement on No Downward Revision of Conversion Price of "Lionco Convertible Bonds"
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Resignation of Secretary of the Board of Directors and Deputy General Manager
Later from Lionco Pharmaceutical
- Announcement on Abnormal Fluctuations in Stock Trading
- Indicative Announcement on "Lionco Convertible Bonds" Expected to Meet Conditions for Revising Conversion Price
- Announcement on Selection of the Subsidiary's Product Huperzine A for Injection in the Inter-Provincial Alliance Centralized Procurement
- Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
- Announcement on Resolutions of the 12th Meeting of the 5th Board of Directors
Follow Lionco Pharmaceutical into a list and get an email when it puts out news.
Follow Lionco Pharmaceutical